Listen "BRCA Reversion Mutations"
Episode Synopsis
BRCA revision mutations may explain some of the limited benefit seen in long-term follow-up studies with PARP inhibitors.
Bibliography:
1: BRCA reversion mutations predict resistance. https://doi.org/10.1158/2159-8290.CD-18-0715
2: SOLO3 Final OS Data. https://doi.org/10.1200/JCO.24.00933
3: Elucidating acquired PARP inhibitor resistance in advanced prostate cancer. https://doi.org/10.1016/j.ccell.2024.10.015
Bibliography:
1: BRCA reversion mutations predict resistance. https://doi.org/10.1158/2159-8290.CD-18-0715
2: SOLO3 Final OS Data. https://doi.org/10.1200/JCO.24.00933
3: Elucidating acquired PARP inhibitor resistance in advanced prostate cancer. https://doi.org/10.1016/j.ccell.2024.10.015
More episodes of the podcast OncoPharm
Iberdomide
20/08/2026
Kidney Cancer in a Nutshell
13/08/2026
Small Cell Lung Cancer and CINV Updates
06/08/2026
Zidesamtinib & PPIs in Pacific
30/07/2026
Gedatolisib et al
23/07/2026
Endurance Part 2
16/07/2026
A Decade of CAR-T, Ocra-T, & POLARGO
09/07/2026
Breast Cancer Updates and T-Cell Stemness
25/06/2026
ASCO '26
11/06/2026
